UK markets closed

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
41.53+2.22 (+5.65%)
As of 01:17PM EDT. Market open.
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-144,876
-141,429
-112,325
-70,511
-59,780
-
Depreciation & amortisation
3,057
3,008
2,896
3,068
3,929
-
Deferred income taxes
-
0
0
-227
-1,167
-
Stock-based compensation
26,752
23,890
15,611
8,953
3,915
-
Change in working capital
3,978
13,462
-3,898
-1,054
-299
-
Other working capital
-120,937
-109,109
-105,560
-62,158
-41,956
-
Other non-cash items
-
-
-6,862
-1,405
-4,218
-1,294
Net cash provided by operating activities
-119,360
-107,291
-103,732
-60,909
-40,404
-
Cash flows from investing activities
Investments in property, plant and equipment
-1,577
-1,818
-1,828
-1,249
-1,552
-
Purchases of investments
-742,893
-424,561
-188,965
-389,881
-220,321
-
Sales/maturities of investments
270,908
320,597
280,666
174,947
123,600
-
Other investing activities
-
-
69
27
55
20
Net cash used for investing activities
-473,562
-105,782
89,942
-216,156
-98,218
-
Cash flows from financing activities
Debt repayment
-
-
0
0
-2,962
0
Common stock issued
648,520
216,222
0
269,893
170,792
-
Net cash used provided by (used for) financing activities
653,876
218,458
4,076
272,372
171,226
-
Net change in cash
60,954
5,385
-9,714
-4,693
32,604
-
Cash at beginning of period
54,123
29,429
39,143
43,836
11,232
-
Cash at end of period
115,077
34,814
29,429
39,143
43,836
-
Free cash flow
Operating cash flow
-119,360
-107,291
-103,732
-60,909
-40,404
-
Capital expenditure
-1,577
-1,818
-1,828
-1,249
-1,552
-
Free cash flow
-120,937
-109,109
-105,560
-62,158
-41,956
-